PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-208 manufacturers

Filters

1 products found

pp-208

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Trigeminal neuralgia (TN) — treatment of neuropathic facial pain Clinical stage: Phase 2 — randomised double-blind trial ongoing Modality: Small molecule (first-in-class GABRA5 negative allosteric modulator) Mechanism / Target: First-in-class GABA-A receptor α5 subunit (GABRA5) negative allosteric modulator (NAM); reduces trigeminal pain sensitisation caused by nerve root injury; selective mechanism targeting pathological central sensitisation while preserving normal GABA function and avoiding CNS depression Route / form: Oral Differentiation: First-in-class GABRA5 negative allosteric modulator; targets the root cause of trigeminal pain sensitisation (vs. carbamazepine/oxcarbazepine which only suppress neural firing); FDA Orphan Drug Designation; no CNS sedation; no approved targeted therapy for TN with novel mechanism;
Manufacturer #39345
Founded in 2014, this innovation-driven biopharmaceutical company develops Rx small molecule therapeutics for pain, inflammation, and CNS diseases through proprietary medicinal chemistry platforms. Novel mechanism-based oral and injectable candidates advance through domestic and global clinical development stages. Committed to delivering innovative therapies for significant unmet needs in neurology and pain.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.